efalizumab

/EH1 F AH0 L AH0 Z UW1 M AE1 B/
noun
  1. 1

    (pharmacology) A recombinant humanized monoclonal antibody, formerly available to treat autoimmune diseases, especially psoriasis, by binding CD11a of lymphocyte function-associated antigen 1, and associated with fatal brain infections.